The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ACTION-1 phase Ib/3 trial of RYZ101 in somatostatin receptor subtype 2–expressing (SSTR2+) gastroenteropancreatic neuroendocrine tumors (GEP-NET) progressing after 177Lu somatostatin analogue (SSA) therapy: Initial safety analysis.
 
Michael Morris
Employment - Advanced Molecular Imaging and Therapy
Stock and Other Ownership Interests - Moderna Therapeutics
Consulting or Advisory Role - Gentem Health
Patents, Royalties, Other Intellectual Property - U.S. Patent No. 20220176040 SYSTEM AND METHOD FOR ADMINISTERING RADIOACTIVE AGENTS TO A SUBJECT.
Travel, Accommodations, Expenses - Advanced Molecular Imaging and Therapy
 
Gary A. Ulaner
Honoraria - GE Healthcare; Lantheus Medical Imaging
Consulting or Advisory Role - GE Healthcare; ImaginAb; Lantheus Medical Imaging; POINT Biopharma
Speakers' Bureau - GE Healthcare; Lantheus Medical Imaging
Research Funding - GE Healthcare; Genentech; Lantheus Medical Imaging; Puma Biotechnology; Sanofi
Expert Testimony - GE Healthcare
Travel, Accommodations, Expenses - Lantheus Medical Imaging
 
Daniel M. Halperin
Consulting or Advisory Role - Camurus; Chimeric Therapeutics; Crinetics Pharmaceuticals; Harbour BioMed; Ipsen; Isotopen Technologien; Novartis; Progenics; Radiomedix; Tersera
Research Funding - Advanced Accelerator Applications (Inst); Camurus (Inst); Genentech/Roche (Inst); Isotopen Technologien (Inst); RayzeBio (Inst); Tarveda Therapeutics (Inst); Thermo Fisher Scientific (Inst)
 
Jonathan R. Strosberg
Consulting or Advisory Role - Tersera
Speakers' Bureau - Ipsen
Research Funding - ITM Solucin (Inst); Novartis (Inst)
 
Samuel H. Mehr
No Relationships to Disclose
 
Daneng Li
Consulting or Advisory Role - Adagene; AstraZeneca; Delcath Systems; Eisai; Exelixis; Genentech; Ipsen; Merck; MINA THERAPEUTICS; QED Therapeutics; Tersera
Speakers' Bureau - Coherus Biosciences; Eisai; Exelixis; Ipsen; SERVIER; Tersera
Research Funding - AstraZeneca (Inst); Brooklyn ImmunoTherapeutics (Inst)
 
Heloisa P. Soares
Consulting or Advisory Role - AstraZeneca; Exelixis; Helsinn Therapeutics; Incyte; Ipsen; Pfizer; TerSera
(OPTIONAL) Uncompensated Relationships - NCCN; North American Neuroendocrine Tumor Society
 
Lowell Brian Anthony
Stock and Other Ownership Interests - Doximity
Honoraria - Boehringer Ingelheim; Curium Pharma; Tersera
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Camurus (Inst); Crinetics Pharmaceuticals (Inst); RayzeBio (Inst)
 
Sandy Diana Kotiah
Consulting or Advisory Role - Bristol-Myers Squibb
 
Heather Jacene
Honoraria - Blue Earth Diagnostics; Munrol
Consulting or Advisory Role - Advanced Accelerator Applications; spectrum dynamics
Research Funding - Blue Earth Diagnostics (Inst); GTx (Inst); Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Marianne E. Pavel
Honoraria - Advanced Accelerator Applications; Boehringer Ingelheim; Hutchison MediPharma; IPSEN; Lilly; Riemser
Consulting or Advisory Role - Advanced Accelerator Applications; IPSEN
Travel, Accommodations, Expenses - Hutchison MediPharma; IPSEN
 
Pamela L. Kunz
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Amgen; Crinetics Pharmaceuticals; Genentech/Roche; HUTCHMED; Ipsen; ITM Isotope Technologies Munich; Natera
Research Funding - Advanced Accelerator Applications/Novartis (Inst)
 
Denis Vasconcelos Ferreira
Employment - Bayer; RayzeBio
Stock and Other Ownership Interests - Bayer; Medtronic; RayzeBio
 
Joanne Li
Employment - RayzeBio
Stock and Other Ownership Interests - RayzeBio
 
Kimberly Ma
Employment - RayzeBio
Stock and Other Ownership Interests - RayzeBio
 
Jessica Rearden
Employment - RayzeBio
Stock and Other Ownership Interests - RayzeBio
 
Susan Moran
Employment - QED Therapeutics; RayzeBio
Leadership - BioAtla
Stock and Other Ownership Interests - BioAtla; BridgeBio Pharma; QED Therapeutics; RayzeBio
Consulting or Advisory Role - Olema Pharmaceuticals
Patents, Royalties, Other Intellectual Property - PCT/US20/34881: "METHODS OF TREATING CHOLANGIOCARCINOMA" PCT/US20/35140: "METHODS FOR TREATING URINARY SYSTEM CANCERS"; Stabilized Compositions of Radionuclides and Uses Thereof
 
Thomas A. Hope
Stock and Other Ownership Interests - Curium Pharma; RayzeBio
Honoraria - GE Healthcare
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Curium Pharma; Ipsen; ITM Isotope Technologies Munich
Research Funding - Advanced Accelerator Applications (Inst); Clovis Oncology (Inst); GE Healthcare (Inst); Lantheus Medical Imaging (Inst); Philips Healthcare (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Simron Singh
Employment - Sanofi (I)
Honoraria - Advanced Accelerator Applications/Novartis; IPSEN
Research Funding - Novartis (Inst)